Home > Healthcare > Medical Devices > Therapeutic Devices > Insulin Pump Market

Insulin Pump Market Trends

Report ID: GMI7983
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Insulin Pump Market Trends

Technological advancements in insulin pumps are contributing to improved diabetes management, enhanced patient satisfaction, and increased adoption of insulin pump therapy. Advances in miniaturization have led to smaller and quieter insulin pumps, making them more comfortable for users to wear throughout the day.

Smart insulin pumps often come with connectivity features, allowing users to monitor and control the device through smartphone apps. This enhances convenience and accessibility for users, enabling them to manage their diabetes discreetly.
Integration with continuous glucose monitoring (CGM) systems allows real-time monitoring of glucose levels. This enables more precise insulin delivery, reducing the risk of hypoglycemia and improving overall glucose control.
Insulin pumps are equipped with data storage capabilities, allowing users and healthcare professionals to analyze trends in glucose levels over time. This data-driven approach helps in making informed decisions about insulin dosages and overall digital diabetes management.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Insulin pump industry size was worth USD 5.3 billion in 2023 and is set to grow at a 12.4% CAGR from 2024 – 2032 driven by the growing awareness and education and the rising prevalence of diabetes.

The devices segment generated USD 4.5 billion in revenue in 2023 and is estimated to record substantial growth through 2032 owing to their user-friendly design with simple insertion processes and minimal steps for activation.

North America insulin pump industry reached USD 2.3 billion in revenue in 2023 and is estimated to expand at a robust pace through 2032 owing to the availability of reimbursement policies and coverage for insulin pumps by healthcare insurers in the region.

Some of the leading insulin pump companies are Debiotech S.A., F. Hoffmann La Roche AG, Insulet Corporation, Lenomed Medical, Medtronic plc, MicroPort Scientific Corporation, Nipro Corporation, Tandem Diabetic Care Inc., Terumo Corporation, ViCentra B.V., and Ypsomed.